PROM1 and glioblastoma: Selected miRNAs are differentially expressed in CD133+ and CD133-GBM cells; miR9/9* are highly expressed in the stem cell fraction, where they appear to act as oncogenes by inhibiting CAMTA1, a tumor suppressor gene that appears to regulate cell proliferation [74].